Medical affairs

Differentiate value in the real world by anticipating, identifying and prioritizing the evidence needs of all your stakeholders.

Let's start a conversation

Parexel’s integrated evidence solutions inform decision-making across the development lifecycle 

We know that medical affairs teams navigate an evolving landscape with multiple stakeholder requirements. Through this, we share the same goal – to deliver medicines to patients. We support leaders in medical affairs to:

  • Stay current and compliant with emerging regulatory requirements
  • Balance scientific integrity with commercial interests
  • Generate and communicate scientific evidence 
  • Build and maintain KOL relationships
  • Increase the impact of the patient voice 

 

+
years of experience in delivering evidence and communicating value
+
RWE projects in the past 5 years
+
MSLs hired and deployed

Global medical, epidemiological and regulatory expertise

Our expertise spans all therapeutic areas and includes in-depth disease landscape analysis, strategies to optimize and expedite regulatory pathways, and strategic product and clinical development planning. Our team excels in protocol development and optimization, ensuring studies are scientifically rigorous and aligned with your objectives. With our expertise in engaging with health authorities and facilitating regulatory submissions, we ensure a smooth and efficient process. Leveraging our strong scientific leadership and deep knowledge of epidemiology, we provide valuable insights to inform your decision-making. 

Learn more

HEOR and market access consultancy and implementation

We deliver literature reviews, economic modeling, outcome measure assessments, global pricing and market access expertise, P&MA strategies, payer engagement, HTA submissions, local market access planning, evidence synthesis and meta-analysis, as well as value communication. Our goal is to generate evidence that informs decisions, optimizes value, and helps our medical affairs customers to articulate the value of their products to maximize their impact in the market.

Learn more

Breadth of real-world evidence expertise and study delivery

Parexel’s Real World Research team develops strategies, identify and apply the right data sources that generate RWE throughout the product lifecycle to help differentiate your products, beginning at the earliest stages of development. We are committed to helping our medical affairs customers to meet the expectations of regulators, payers, physicians and patients and give you the competitive edge – through an integrated evidence strategy.

Learn more

Specialty services, including MSL deployment and medical info call center

By establishing and augmenting medical affairs capabilities, The Medical Affairs Company (TMAC) delivers staffing solutions through global outsourcing, talent acquisition via executive search and compliant medical information with call center solutions, as well as medical writing and informatics and well as medical meeting coverage. With more than 20 years’ experience in medical affairs, and part of Parexel since 2017, TMAC plans, develops and executes cost-effective solutions for medical affairs leaders. 

Learn more

Medical communications for patients, payers and HCPs

We understand that a effective communication of a product’s clinical and real-world evidence can’t succeed without reliably established insights and alignment on strategic objectives. Our integrated experts support across the development lifecycle, providing a continuum of flexible, strategic support and expert implementation including: strategic communication planning, thought leader identification, education and training, full-service meetings and events, patient-focused communications solutions, publication planning and execution and field medical tools for scientific exchange. 

Learn more

Patient insights, engagement and advocacy

As our customers strive to increase the impact of the patient voice, Parexel provides a 360-degree patient-first portfolio to ensure that the patient is represented at every step, through insights, engagement and advocacy. At Parexel, we work With Heart™ to make protocols more compelling to sites and patients, engage more representative patient populations, include patient advocacy group experts as part of design and delivery teams, and create customizable engagement plans by country.

Learn more

Leading Insights

Blog

Patient-guided oncology trials: Why the patient perspective is essential to success

Jun 4, 2024

Blog

Accelerating Delivery and Patient Access to Rare Disease Treatments – Highlights from World Orphan Drug Congress

May 2, 2024

Blog

Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression

Apr 23, 2024

Blog

To establish market access, start with unmet need: Why patient insights are central to reimbursement strategy

Apr 10, 2024

Whitepaper

Combining data tokenization and real-world patient insights to bridge the gap for a more diverse and complete dataset

Apr 2, 2024

Blog

Deriving meaningful insights from real-world data for diverse Alzheimer’s research studies

Mar 19, 2024

Blog

Opportunities and strategies for accelerating patient access to treatments for Alzheimer’s disease

Feb 23, 2024

Article

Near-term strategies for biotech drug developers facing shifting healthcare dynamics

Feb 14, 2024

Blog

As more neuroscience drugs are approved, the value proposition takes center stage

Feb 14, 2024

Blog

Using ethical AI to streamline HEOR

Jan 26, 2024

Video

Insights with Goldman Sachs Part 6: Generating investor interest

Jan 26, 2024

Video

Insights with Goldman Sachs Part 2: How pharma is using M&A for growth and innovation

Jan 26, 2024